ABSTRACT: The competitive interactions of genetically distinct isolates of Giardia duodenalis with different growth rates were studied in vitro. Electrophoretic analysis of mixed cultures showed that competition between 2 cloned isolates occurs under normal in vitro culture conditions, with faster-growing isolates outcompeting those with slower growth rates. The addition of sublethal concentrations of metronidazole to clonal mixtures in vitro prevented the competitive exclusion, which was seen in normal culture. This apparently occurred because the drug reduced the growth rate of the faster-growing but not the slower-growing clone.
Although the mechanisms of transmission are understood, the epidemiology of giardiasis is complicated by heterogeneity in the causative organism (Thompson et al., 1993; Erlandsen, 1994) . Only 1 species of Giardia, G. duodenalis (syn. G. intestinalis, G. lamblia), is believed to infect humans, yet differences in virulence, pathogenicity, infectivity, growth, drug sensitivity, and antigenicity have been reported (reviewed in Thompson and Meloni, 1993) . This pronounced phenotypic variability has been shown by numerous workers to be reflected by considerable genetic diversity in G. duodenalis isolated from humans and other mammals from many localities throughout the world (Nash et al. Genetic diversity in G. duodenalis is extensive with some clones widely distributed and others localized to a particular endemic focus (Meloni et al., 1988 (Meloni et al., , 1989 (Meloni et al., , 1995 (Fig. 2) .
Mixed cultures of clones BAH44C9 and BAH3C17 were established in 5-ml borosilicate tubes at a seeding density of 40,000 trophozoites per ml in the proportions 1:1, 3:1, 1:3. As cultures reached monolayer stage, 1 ml was removed by 1 of 3 methods and used to establish cultures in 16-ml tubes: (1) samples of nonadhering trophozoites were subcultured from undisturbed cultures maintained at 370C; (2) representative samples of the total trophozoite population were taken after incubating the tube on ice for 15 min and dislodging trophozoites by mixing; and (3) adhering trophozoites were sampled after all media was tipped from the tube and the tube refilled with media, incubated on ice for 15 min and trophozoites dislodged by mixing. As 16-ml cultures reached monolayer stage, 1 ml of the media was removed after ice immersion and subcultured into 60-ml flasks, as described above. Once trophozoites had attained monolayer growth in 60-ml flasks, they were collected following ice immersion. A total of 50 replicate mixed cultures of isolates BAH3C17 and BAH44C9 were analyzed for the 2 isoenzymes. In 48 of these mixtures, the faster-growing isolate (BAH3C17) was the only isolate detected. Under the null hypothesis of no competition between isolates, this result is extremely unlikely to occur by chance (using the normal approximation to the binomial distribution, Z = 16.3, P < 0.001). Of the 2 exceptions, in 1 replicate (ratio 1:1, adhering trophozoites only subcultured) a mixture of the 2 isolates with BAH44C9 in higher concentrations was found, based on enzyme staining intensity after electrophoresis, whereas the other replicate (ratio 1(BAH3C17): 3(BAH44C9), total random sample of trophozoites subcultured) showed only BAH44C9. These 2 cultures took 3 days longer than comparative cultures to reach monolayer stage (12 and 13 days, respectively).
Mixed cultures of clones P1 C10 and BAH44C6 were established as described above but using only equal proportions of each isolate and subculturing only by method (2). Ten replicate mixed cultures were grown in normal in vitro culture media, and 10 in media containing 0.2 iM metronidazole. In all 10 mixtures without metronidazole the faster-growing isolate (P 1 C10) was the only isolate detected (Figs. 3, 4) , again a result inconsistent with the null hypothesis of no competition between isolates (from the binomial test, P < 0.01). By contrast, both isolates were detected in all 10 mixtures containing metronidazole.
These studies have shown that competition between 2 cloned isolates of Giardia does occur under normal in vitro culture conditions thus supporting the findings of Mayrhofer et al. (1992) and Upcroft and Upcroft (1994). In 96% (BAH3C17 vs. BAH44C9) and 100% (PIC10 vs. BAH44C6) of mixed cultures, the faster-growing isolate (BAH3C 17 and P1C 10, respectively) outcompeted the other. With the first experiment, this occurred even when the slower-growing isolate was seeded at 3 times the concentration of the faster-growing isolate. The concentration of trophozoites in each experimental sample was between 60 and 120 x 106 trophozoites per 30 Al. The electrophoretic technique employed in our laboratory is capable of detecting a minimum concentration of 3.2 x 106 trophozoites (data not shown), which is approximately 5% of the total sample. Therefore, whereas it cannot be assumed that the slower-growing isolates were completely absent, they constituted less than 5% of the total sample. This result was expected. The growth curves of single-clone cultures usually show a positive correlation between growth rate and maximum stationary phase concentration, suggesting that faster-growing isolates should always prevail in mixed cultures, unless there are highly asymmetric interactions between the clones (Finley and Dvorak, 1987) .
The addition of sublethal concentrations of metronidazole to clonal mixtures prevented the competitive exclusion that was seen in normal culture. This apparently occurred because the drug reduced the growth rate (and presumably also the maximum stationary phase concentration) of the faster-growing (P 1 C10) but not the slower-growing ( The hypotheses we have confirmed in this study (namely that competition occurs between clones of G. duodenalis in vitro, and that its effects are ameliorated by exposure to metronidazole because of differential effects of the drug on growth of the clones) are thus necessary but not sufficient conditions to support our suggestion that genetic heterogeneity in some populations of G. duodenalis is due to regular, suboptimal drug treatment. Our next step will be to examine the dynamics of mixed infections and drug treatment in a suitable animal model.
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